BiomX Revenue and Competitors
Estimated Revenue & Valuation
- BiomX's estimated annual revenue is currently $15.5M per year.
- BiomX's estimated revenue per employee is $155,000
Employee Data
- BiomX has 100 Employees.
- BiomX grew their employee count by 4% last year.
BiomX's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Quality Control | Reveal Email/Phone |
3 | VP Research | Reveal Email/Phone |
4 | VP Development Projects | Reveal Email/Phone |
5 | VP CMC | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | SVP Finance & Operations | Reveal Email/Phone |
8 | Head In-vivo | Reveal Email/Phone |
9 | Director Intellectual Property | Reveal Email/Phone |
10 | Senior Director and Co-founder | Reveal Email/Phone |
BiomX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.1M | 78 | 7% | $47.7M | N/A |
#2 | $6M | 39 | 18% | N/A | N/A |
#3 | $2.8M | 18 | 0% | N/A | N/A |
#4 | $1.9M | 12 | -29% | N/A | N/A |
#5 | $1350.2M | 8711 | 6% | N/A | N/A |
#6 | $1350.2M | 8711 | 6% | N/A | N/A |
#7 | $1350.2M | 8711 | 6% | N/A | N/A |
#8 | $6M | 39 | -11% | N/A | N/A |
#9 | $2.8M | 18 | 6% | N/A | N/A |
#10 | $15.5M | 100 | 4% | N/A | N/A |
What Is BiomX?
BiomX is a microbiome drug discovery company developing customized phage therapies that target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease (IBD) and cancer. We discover and validate proprietary bacterial targets and customize our natural and engineered phage compositions against these targets. The Company?s platforms use computational and synthetic biology and cutting-edge research from Profs. Rotem Sorek, Ph.D., Eran Elinav, M.D., Ph.D., and Eran Segal, Ph.D., of The Weizmann Institute of Science; and Professor Timothy K. Lu, M.D., Ph.D., of The Massachusetts Institute of Technology. Investors in the Company include OrbiMed Israel Incubator LP, Johnson & Johnson Development Corporation Inc., Takeda Ventures, Inc., Seventure Partners, Mirae Asset Global Investments, and SBI.
keywords:N/A
N/A
Total Funding
100
Number of Employees
$15.5M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
BiomX News
Biomx Inc (PHGE) is down -6.59%% today. Overall Score - 40. PHGE has an Overall Score of 40. Find out what this means to you and get the rest of...
BiomX Inc. (NYSE:PHGE) Q4 2021 Earnings Conference Call March 30, 2022 8:00 AM ET. Company Participants. Jonathan Solomon Chief Executive...
BiomX is a clinical-stage microbiome company developing both natural and engineered phage cocktails designed to target and destroy bacteria in...
NESS ZIONA, Israel, July 26, 2021 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announced today it has entered into a definitive ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $32.8M | 100 | 6% | N/A |
#2 | $15.5M | 100 | 30% | N/A |
#3 | $32.8M | 100 | -3% | N/A |
#4 | $30.5M | 100 | 8% | N/A |
#5 | $14.5M | 100 | N/A | N/A |